Type 2 diabetes trials in Australia

In Australia 33 Also abroad 1200

33 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Blacktown, Heidelberg, Melbourne, Oaklands Park, St Leonards
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Blacktown, Camperdown, Heidelberg, Meadowbrook, Melbourne, Oaklands Park
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Botany, Box Hill, Brisbane, Camberwell, Geelong, Heidelberg West, Merewether, Oaklands Park, St Leonards, Waitara
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Not yet taking people in Australia
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Adelaide, Box Hill, Brisbane, Frankston, Garran, Ipswich, Melbourne, St Leonards, Waitara
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Botany, Camberwell, Charlestown, St Albans, St Leonards, Waitara
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Where
Camperdown, Meadowbrook, Melbourne, Oaklands Park
Age
18 years and over
People
600 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07754461
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Adelaide, Bedford Park, Blactown, Burwood, Camperdown, Chelmer, Chermside, Clayton, Concord, Epping, Frankston, Garran, Herston, Hobart, Hoppers Crossing, Ipswich, Joondalup, Leabrook, Liverpool, Malvern, Mulgrave, Murdoch, New Lambton Heights, Southport, St Leonards, Subiaco, Toowoomba
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Botany, Camberwell, Charlestown, Helensvale, Maroubra, Waitara
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Botany, East Toowoomba, Fitzroy, Heidelberg Heights, Kingswood, Melbourne, Parkville, Penrith, St Leonards
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
No phaseEnrolling by invitation
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Where
Fitzroy, Melbourne, Randwick
Age
22 years and over
People
50 worldwide
Run by
Endogenex, Inc.
See details and how to joinNCT07197788
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Botany, Camberwell, Charlestown, Maroubra, St Albans, St Leonards
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Where
Adelaide, Castle Hill, Charlestown, Melbourne, New Lambton Heights, Sydney
Age
18 years to 75 years
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00
Phase 3Taking people
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Where
Bentley
Age
55 years to 80 years
People
10,000 worldwide
Run by
Montreal Heart Institute
See details and how to joinNCT05633810 · EU 2024-516646-19-00
Phase 1/2Taking people
VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes
Where
Melbourne
Age
18 years to 65 years
People
29
Run by
Kriya Therapeutics, Inc.
See details and how to joinNCT07829302
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Birtinya, Camberwell, Campbelltown, Gosford, Liverpool, Merewether, South Brisbane
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Botany, Brisbane, Camberwell, Ipswich, Kanwal, Meadowbrook, Melbourne, Merewether, Norwood, Sippy Downs
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
Phase 2Taking people
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Where
Sydney
Age
18 years to 70 years
People
44
Run by
Victor Chang Cardiac Research Institute
See details and how to joinNCT06820281
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
Where
Campbelltown, East Toowoomba, Heidelberg Heights, Parkville, St Leonards
Age
18 years and over
People
600 worldwide
Run by
AstraZeneca
See details and how to joinNCT07664553 · EU 2025-523935-20-00
Phase 1/2Taking people
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Where
Morayfield, Nedlands
Age
18 years to 65 years
People
150 worldwide
Run by
Arrowhead Pharmaceuticals
See details and how to joinNCT06937203
Phase 2Not yet taking people in Australia
TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy
Where
Maroochydore, Melbourne, Sydney
Age
18 years to 70 years
People
48
Run by
Myopharm Limited
See details and how to joinNCT07139405
No phaseEnrolling by invitation
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Where
Fitzroy
Age
18 years and over
People
500 worldwide
Run by
Endogenex, Inc.
See details and how to joinNCT07197775
No phaseTaking people
Closed-loop in Adults With Type 2 Diabetes
Where
Melbourne
Age
18 years and over
People
224 worldwide
Run by
University of Cambridge
See details and how to joinNCT06579404
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Where
Castle Hill, Chelmer, Gosford, Reservoir, St Albans
Age
18 years and over
People
465 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00
No phaseTaking people
Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes
Where
Adelaide
Age
18 years to 70 years
People
8
Run by
University of Adelaide
See details and how to joinNCT06942195
Phase 2Not yet taking people in Australia
Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin
Where
Fitzroy, Heidelberg, Melbourne, Parkville
Age
24 years to 85 years
People
115
Run by
St Vincent's Hospital Melbourne
See details and how to joinNCT07225465